97812353 - MOL2MED

Information

• Trademark
• 97812353

• Source

• Serial Number

  97812353

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  February 26, 2023
  a year ago

• Transaction Date

  October 26, 2024
  3 months ago

• Status Date

  October 25, 2024
  3 months ago

• Location Date

  October 25, 2024
  3 months ago

• First Use Anywhere Date

  January 11, 2023
  2 years ago

• First Use In Commerce Date

  January 11, 2023
  2 years ago

• Status Code

  654

• Current Location

  TMEG LAW OFFICE 104

  Employee Name

  CANTONE, KERI

• Attorney Name

  KEVIN O'KEEFE

• Owners

  • CRYSTAL PHARMATECH, INC

Case File Statements

• DM0000: The mark consists of the English wording "Mol2Med" in stylized font.
• PM0001: MOL TWO MEDICINE; MOL TO MEDICINE
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: Chemical analysis; Chemical research; Chemical research services; Conducting of feasibility studies in the field of new technologies; Material testing; Product quality evaluation; Research and development of new products for others; Research in the field of physics; Scientific laboratory services; Technological research in the field of medicine

Case File Event Statements

• 3/1/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/16/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/27/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/26/2024 - 3 months ago

  7 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 12/5/2023 - a year ago

  6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 12/5/2023 - a year ago

  4 - SUSPENSION LETTER WRITTEN Type: CNSL

• 12/5/2023 - a year ago

  5 - LETTER OF SUSPENSION E-MAILED Type: GNSL